Jun Li, Ziyong Wang, Ya Zhang, Jing Tan, Ruiqian Li, Haiyang Jiang, Shanghu Qu, Penghui Li. "Neoadjuvant PD-1 inhibitor plus paclitaxel, pingyangmycin, and platinum-based chemotherapy (4P therapy) as a bladder-sparing strategy for high-risk non–muscle-invasive/muscle-invasive bladder cancer: A retrospective cohort study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16606